A SCOTTISH biotech firm that is developing home coronavirus tests has moved to raised £11 million to help scale up manufacturing and develop further Covid-19 testing opportunities.
Clackmannanshire-based Omega Diagnostics has already raised £8m in a heavily oversubscribed subscription of 20,000,000 new ordinary shares of four pence each to both new and existing institutional investors and a number of wealth managers at an issue price of 40 pence per new ordinary share.
It proposes to raise up to the additional £3m by the issue of up to 7,531,100 new ordinary shares at 40p which it said represents a discount of around 27 per cent to the closing mid-market price of 55 pence on Thursday.
READ MORE: Scottish biotech firm takes first order for Covid-19 test
Directors have subscribed for a total of 122,500 shares. It said the discount reflects the rapid rise in the company’s share price from 11 pence in April, immediately prior to announcement of Omega’s participation in the UK Rapid Test Consortium.
Up to £10.5m will be used to exploit further coronavirus opportunities and it also plans to undertake work on its Visitect CD4 HIV-related products.
Colin King, Omega Diagnostics chief executive, said: “This fundraising marks another significant moment in the company’s development and we are pleased with level of support shown from our existing shareholders and new investors in the placing. The fundraising will allow Omega to capitalise on the current opportunities it has regarding Covid-19 and build a strong position in the global health diagnostic market by using its existing skill set and experience with lateral flow devices.
“Furthering these opportunities will allow the company to continue delivering on its mission to improve human health and well-being through innovative diagnostic tests and global partnerships.”
A general meeting is due on July 10 in Alva. Shares closed at 54p, down 1.8 per cent on Friday.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here